Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Status:
Terminated
Trial end date:
2013-10-23
Target enrollment:
Participant gender:
Summary
Based on laboratory studies, donepezil will improve pain relief more than placebo in patients
with chronic neuropathic pain who are currently taking gabapentin or pregabalin.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)